EYLEA HD® and EYLEA® remained the U.S. anti-VEGF category leader in 2024; aggregate U.S. net product sales were $6 billion for full-year 2024, up 1% based on preliminary (unaudited) results EYLEA HD ...
People with severe eczema are at a higher risk for food allergies and asthma. Cellulitis is the likely diagnosis when bacteria infect the skin layers and tissue below the skin. The skin may be ...